Nomura Healthcare Fund is a registered fund series of Delaware Group Equity Funds IV (series S000018873). Net assets $665.0M as of 2026-03-31.
Showing 15 of 106 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| UCB SA | — | $39.2M | 589.64% |
| Regeneron Pharmaceuticals, Inc. | — | $36.3M | 546.10% |
| Pfizer Inc. | — | $32.2M | 483.50% |
| Gilead Sciences Inc. | — | $29.3M | 440.13% |
| AbbVie Inc. | — | $27.2M | 408.83% |
| Merck & Co., Inc | — | $25.9M | 388.92% |
| AstraZeneca PLC | — | $25.7M | 385.93% |
| Chugai Pharmaceutical Co Ltd. | — | $24.8M | 373.20% |
| Eli Lilly & Co. | — | $23.9M | 359.62% |
| Roche Holding AG | — | $21.9M | 330.09% |
| UnitedHealth Group Inc. | — | $18.9M | 284.84% |
| Elevance Health Inc. | — | $18.4M | 277.35% |
| Amgen Inc. | — | $16.5M | 248.68% |
| Viatris Inc | — | $15.8M | 237.71% |
| Boston Scientific Corporation | — | $15.7M | 235.91% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $665.0M |
| 2025-12-31 | $693.6M |
| 2025-09-30 | $658.4M |
| 2025-06-30 | $648.0M |
| 2025-03-31 | $702.3M |
| 2024-12-31 | $701.9M |
| 2024-09-30 | $835.4M |
| 2024-06-28 | $784.2M |